Literature DB >> 12102692

Formulary development at Regence BlueShield--a formula for success.

D S Pete Fullerton, Debbie Scott Atherly.   

Abstract

Mesh：

Year:  2002        PMID： 12102692     DOI： 10.1046/j.1524-4733.2002.54002.x

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus.

Authors:  Joe W Ramsdell; Seth N Braunstein; Jennifer M Stephens; Christopher F Bell; Marc F Botteman; Scott T Devine
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.